Suppr超能文献

鉴定激肽原1作为有结直肠癌家族史患者结直肠腺瘤的血清蛋白标志物。

Identification of Kininogen 1 as a Serum Protein Marker of Colorectal Adenoma in Patients with a Family History of Colorectal Cancer.

作者信息

Yu Jiekai, Huang Yanqin, Lin Chen, Li Xiaofen, Fang Xuefeng, Zhong Chenhan, Yuan Ying, Zheng Shu

机构信息

Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Department of Medical Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

J Cancer. 2018 Mar 8;9(3):540-547. doi: 10.7150/jca.22405. eCollection 2018.

Abstract

The serum protein markers of colorectal adenoma in patients with a family history of colorectal cancer have been rarely reported. Serum samples from colorectal adenoma patients with or without a family history of colorectal cancer and healthy controls were profiled using Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF-MS). The model to distinguish colorectal adenoma patients with a family history of colorectal cancer from atypical hereditary colorectal families (CRA-H) and sporadic colorectal adenoma patients without a family history of colorectal cancer (CRA-S) was established with 85.0% accuracy. The model distinguishing CRA-H from healthy individuals was established with 90.0% specificity and 86.7% sensitivity. Additionally, five peaks (2202, 5821, 3260, 2480, and 2218) showing differential expression in advanced colorectal adenoma patients with a family history of colorectal cancer were selected. The protein Kininogen 1 (KNG1) was identified in colorectal adenoma patients and validated using Western Blotting. KNG1 may be a biomarker for colorectal adenoma patients with a family history of colorectal cancer.

摘要

具有结直肠癌家族史的结直肠腺瘤患者的血清蛋白标志物鲜有报道。使用基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)对有或无结直肠癌家族史的结直肠腺瘤患者及健康对照者的血清样本进行分析。建立了区分具有结直肠癌家族史的结直肠腺瘤患者与非典型遗传性结直肠家族(CRA-H)以及无结直肠癌家族史的散发性结直肠腺瘤患者(CRA-S)的模型,准确率为85.0%。建立了区分CRA-H与健康个体的模型,特异性为90.0%,敏感性为86.7%。此外,选择了在具有结直肠癌家族史的晚期结直肠腺瘤患者中显示差异表达的五个峰(2202、5821、3260、2480和2218)。在结直肠腺瘤患者中鉴定出蛋白激肽原1(KNG1),并使用蛋白质印迹法进行验证。KNG1可能是具有结直肠癌家族史的结直肠腺瘤患者的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e46/5845484/c8d8f597b60a/jcav09p0540g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验